IN THE NEWS

The president of Israel, Reuven Rivlin, tested the VOX system during a visit at the Shamir Medical Center

Identification of biomarkers associated with the coronavirus with 98% accuracy following completion of clinical trials

Scentech-Medical purchases 100 units of the VOX system from a German supplier and agrees on collaboration with a distributor in the United Arab Emirates

Innovative Development – Meet Scentech-Medical – Disease and Pathogen Detection in Breath

NextGen to start “Coronavirus Breathalyzer” tests; Projections: $100 million in 2021 revenue

NextGen Biomed trial brings Covid-19 breath test nearer

New development: a breathalyzer that detects whether you have the Coronavirus

Israel Export Institute – Yaniv Chevron, Scentech-Medical CEO, discusses the new standard we will all have to get used to: “Biological Security”